CWM
RNAM

CIBC World Markets’s Avidity Biosciences RNAM Stock Holding History

CIBC World Markets’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$552K Buy
+7,658
New +$495K ﹤0.01% 813
2025
Q2 		$400K Sell
14,101
-11,102
-44% -$331K ﹤0.01% 965
2025
Q1 		$744K Buy
25,203
+14,817
+143% +$461K 0.01% 805
2024
Q4 		$302K Buy
+10,386
New +$434K ﹤0.01% 932

Other funds holding RNAM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC World Markets's RNAM Position: Q4 2025 in Review

CIBC World Markets opened a new position in Avidity Biosciences (RNAM) in Q4 2025: 7,658 shares worth $552K. The stake represents ﹤0.01% of the portfolio and ranks #813 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in RNAM as recently as Q2 2025.

CIBC World Markets first reported a position in RNAM in Q4 2024 and has held it in 4 quarters since. The position peaked at $744K in Q1 2025. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • CIBC World Markets held 7,658 shares of Avidity Biosciences worth $552K as of Q4 2025.
  • Avidity Biosciences was a new CIBC World Markets position in Q4 2025.
  • Avidity Biosciences made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #813 holding.
  • CIBC World Markets first reported a position in Avidity Biosciences in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Avidity Biosciences position peaked at $744K in Q1 2025.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.